Concepedia
Statistics
Publications
8
Citations
737
H-Index
Active since
2000
Affiliations
Novartis (Switzerland)(Current)
Novartis Institutes for BioMedical Research
Novartis (United States)
Andreas Mahl is an author at Novartis (Switzerland) specializing in pharmacy, pharmacology, and renal pathophysiology.
Publications per year
2000–2020
Urinary clusterin, cystatin C, β2-microglobulin and total protein as markers to detect drug-induced kidney injury
Frank Dieterle, Elias Perentes, André Cordier et al. · Nature Biotechnology · 2010 · 331 citations
Medicine, Nephrology, Pharmacology +14
A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function
Josef Ozer, Frank Dieterle, Sean P. Troth et al. · Nature Biotechnology · 2010 · 202 citations
Medicine, Nephrology, Renal Pathology +14
Poly(ethylene carbonate)s, part II11Part I: see Ref. [15].: degradation mechanisms and parenteral delivery of bioactive agents
Georg H. Stoll, Fritz Nimmerfall, Murat Acemoglu et al. · Journal of Controlled Release · 2001 · 65 citations
Pharmacy, Pharmaceutics, Drug Delivery +16
Comparison of clinical pathology parameters with two different blood sampling techniques in rats: retrobulbar plexus versus sublingual vein
Andreas Mahl, Peter Heining, Peter Ulrich et al. · Laboratory Animals · 2000 · 46 citations
Veterinary Medicine, Animal Sciences, Physiology +11
Opportunities for use of one species for longer-term toxicology testing during drug development: A cross-industry evaluation
Helen Prior, Paul Baldrick, Sonja Beken et al. · Regulatory Toxicology and Pharmacology · 2020 · 40 citations · Full text
Pharmacy, Pharmacology, Toxicology +16
1–5 of 8